According to their official research Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine pdf

and the supplemental material p12 Pg12

The Vx reduces cases of positive tests vs placebo are 800 vs 80, deaths at 15 vs 14.

4% of non Vxd tested positive for coof vs 0.4% who got the Vx.

Adverse event analyses during the blinded period are provided for 43,847 ≥16-year-olds. Reactogenicity events among participants not in the reactogenicity subset are reported as adverse events, resulting in imbalances in adverse events (30% vs 14%), related adverse events (24% vs 6%), and severe adverse events (1.2% vs 0.7%) between BNT162b2 and placebo groups. Decreased appetite, lethargy, asthenia, malaise, night sweats, and hyperhidrosis were new adverse events attributable to BNT162b2 not previously identified in earlier reports. Few participants had serious adverse events or adverse events leading to study withdrawal. No new serious adverse events assessed as related by investigators were reported after data cut-off for the previous report.

So, even officially, you are far more likely to get an adverse reaction than coof.

You might even conclude that 14 deaths out of 850 cases for non Vxd and 15 deaths out of 77 cases of the Vxd makes the Vx far more dangerous.